Literature DB >> 22923761

Successful α1-antitrypsin replacement therapy in a patient with α1-antitrypsin deficiency and granulomatosis with polyangiitis.

José María Hernández Pérez, Sergio Fumero García, Alberto Alvarez Pío.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22923761     DOI： 10.1093/rheumatology/kes233

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  4 in total

1.  The Diagnostic Value of Alpha-1-Antitrypsin Phenotype in Patients with Granulomatosis with Polyangiitis.

Authors:  M Y Pervakova; V L Emanuel; O N Titova; S V Lapin; V I Mazurov; I B Belyaeva; A L Chudinov; T V Blinova; E A Surkova
Journal:  Int J Rheumatol       Date:  2016-04-10

Review 2.  Clinical utility of alpha-1 proteinase inhibitor in the management of adult patients with severe alpha-1 antitrypsin deficiency: a review of the current literature.

Authors:  David G Parr; Beatriz Lara
Journal:  Drug Des Devel Ther       Date:  2017-07-14       Impact factor: 4.162

3.  Activation of complement component 3 is associated with airways disease and pulmonary emphysema in alpha-1 antitrypsin deficiency.

Authors:  Michael E O'Brien; Laura Fee; Niall Browne; Tomás P Carroll; Paula Meleady; Michael Henry; Karen McQuillan; Mark P Murphy; Mark Logan; Cormac McCarthy; Oliver J McElvaney; Emer P Reeves; Noel G McElvaney
Journal:  Thorax       Date:  2020-01-20       Impact factor: 9.139

4.  C3d Elicits Neutrophil Degranulation and Decreases Endothelial Cell Migration, with Implications for Patients with Alpha-1 Antitrypsin Deficiency.

Authors:  Laura T Fee; Debananda Gogoi; Michael E O'Brien; Emer McHugh; Michelle Casey; Ciara Gough; Mark Murphy; Ann M Hopkins; Tomás P Carroll; Noel G McElvaney; Emer P Reeves
Journal:  Biomedicines       Date:  2021-12-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.